[Ph+ acute lymphoblastic leukemia combined with lung and brain invasive aspergillosis].

This study was aimed to investigate the clinical features and therapy of Ph(+) acute lymphoblastic leukemia (Ph(+)ALL) combined with invasive aspergillosis. A series of examination, including routine blood and bone marrow picture analysis, chest roentgenography, cranial computerized tomography and detection of cell genetics etc were carried out for a Ph(+)ALL patient combined with invasive aspergillosis. This patient received chemotherapy with DVCP, idarubicin and imatinib mesylate and was treated with sporanox and amphotericin B (Amb; including Amb-L) and cerebrotomy for drainage because the invasive aspergillosis occurred during myelosuppression. The results showed that patient gained complete remission and the invasive aspergillosis was controlled successfully. It is concluded that patient with Ph(+)ALL has poor prognosis despite intensive conventional chemotherapy, imatinib mesylate may prove to be an effective treatment for Ph(+)ALL. Because detection rate of the fungus is very low, itraconazole in combination with surgical excision of focus is the best treatment of lung and brain invasive aspergillosis.
AuthorsMei Huang, Jian-Feng Zhou, Dan Ran, Yi-Cheng Zhang, Han-Ying Sun, Wen-Li Liu
JournalZhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology (Zhongguo Shi Yan Xue Ye Xue Za Zhi) Vol. 14 Issue 3 Pg. 610-3 (Jun 2006) ISSN: 1009-2137 [Print] China
PMID16800953 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antifungal Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Itraconazole
  • Imatinib Mesylate
  • Antifungal Agents (therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Aspergillosis (diagnosis, drug therapy)
  • Benzamides
  • Brain Diseases (complications, microbiology)
  • Humans
  • Imatinib Mesylate
  • Itraconazole (therapeutic use)
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (complications)
  • Lung Diseases, Fungal (drug therapy, etiology)
  • Piperazines (administration & dosage)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (complications, genetics, microbiology)
  • Pyrimidines (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: